HCC - Subtypes, stratification and sorafenib

Gregory J. Gores

doi:10.1038/nrgastro.2014.157

HCC - Subtypes, stratification and sorafenib

Gregory J. Gores

Gastroenterology and Hepatology

Research output: Contribution to journal › Review article › peer-review

34 Scopus citations

Abstract

The past 10 years have represented a whirlwind of activity with regard to information on the risk factors, aetiopathogenesis, diagnosis and treatment of hepatocellular carcinoma. I will describe what I consider to be the major advances from both a tumour biology perspective and a clinical perspective over the past 10 years.

Original language	English (US)
Pages (from-to)	645-647
Number of pages	3
Journal	Nature Reviews Gastroenterology and Hepatology
Volume	11
Issue number	11
DOIs	https://doi.org/10.1038/nrgastro.2014.157
State	Published - Nov 5 2014

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1038/nrgastro.2014.157

Cite this

@article{7218ea62bf474490a6164c4178c221ad,

title = "HCC - Subtypes, stratification and sorafenib",

abstract = "The past 10 years have represented a whirlwind of activity with regard to information on the risk factors, aetiopathogenesis, diagnosis and treatment of hepatocellular carcinoma. I will describe what I consider to be the major advances from both a tumour biology perspective and a clinical perspective over the past 10 years.",

author = "Gores, {Gregory J.}",

year = "2014",

month = nov,

day = "5",

doi = "10.1038/nrgastro.2014.157",

language = "English (US)",

volume = "11",

pages = "645--647",

journal = "Nature Reviews Gastroenterology and Hepatology",

issn = "1759-5045",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - HCC - Subtypes, stratification and sorafenib

AU - Gores, Gregory J.

PY - 2014/11/5

Y1 - 2014/11/5

N2 - The past 10 years have represented a whirlwind of activity with regard to information on the risk factors, aetiopathogenesis, diagnosis and treatment of hepatocellular carcinoma. I will describe what I consider to be the major advances from both a tumour biology perspective and a clinical perspective over the past 10 years.

AB - The past 10 years have represented a whirlwind of activity with regard to information on the risk factors, aetiopathogenesis, diagnosis and treatment of hepatocellular carcinoma. I will describe what I consider to be the major advances from both a tumour biology perspective and a clinical perspective over the past 10 years.

UR - http://www.scopus.com/inward/record.url?scp=84908551424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908551424&partnerID=8YFLogxK

U2 - 10.1038/nrgastro.2014.157

DO - 10.1038/nrgastro.2014.157

M3 - Review article

C2 - 25245016

AN - SCOPUS:84908551424

SN - 1759-5045

VL - 11

SP - 645

EP - 647

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

IS - 11

ER -

HCC - Subtypes, stratification and sorafenib

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this